This page brings together practical information for GPs and other primary care clinicians looking for clear, accessible guidance on aspergillosis. It includes resources on when to suspect aspergillosis, differential diagnosis, referral, and patient information that may be useful in consultations.
Quick links
Featured guidance
- ERS learning resources on pulmonary aspergillosis (10/23/2026) - Explore ERS talks and case-based teaching on ABPA, chronic pulmonary aspergillosis and invasive aspergillosis, with sessions on diagnosis, antifungal treatment and complex cases.
Expertise shared across borders: an ABPA case discussion (10/23/2026) - Two sessions from the 2026 ERS Congress highlight the value of sharing expertise across countries and involving patients in respiratory research. One discusses a complex case of allergic bronchopulmonary aspergillosis (ABPA); the other explores how patients can help shape research.
When symptoms remain difficult: keeping the conversation open (9/24/2026) - When symptoms remain difficult despite a diagnosis or treatment, uncertainty can strain the patient–clinician relationship. Explore practical ways to acknowledge their impact, discuss mind–body effects without blame, and agree what happens next.
Itraconazole for aspergillosis: benefits, monitoring and side effects (9/15/2026) - A practical guide to itraconazole for people with aspergillosis: why it is prescribed, how it is monitored, important interactions and side effects.
ABPA in primary care
- ⭐ Allergic Bronchopulmonary Aspergillosis (ABPA): Why Diagnosis Is Missed and Who Needs to Be More Aware - ABPA is often mistaken for difficult asthma or repeated chest infections. Learn the warning signs, blood tests and scan findings that should prompt discussion with a respiratory or asthma specialist.
- 📘 What is ABPA? (Allergic Bronchopulmonary Aspergillosis) - Patient handout for A&E staff who ask what aspergillosis is. What is ABPA? ABPA is an allergic lung condition caused […]
- 🫁 ABPA Treatment: Why Are Steroids First, Even if They Can Increase Fungal Growth? - If you’ve been diagnosed with Allergic Bronchopulmonary Aspergillosis (ABPA), you may have heard that treatment often starts with oral steroids […]
- 🫁 Understanding ABPA, Bronchiectasis & Lung Cavities - A Patient’s Guide to What Happens in the Lungs – and What You Can Do About It 🌿 What is […]
- 📘 Managing IgE Levels in ABPA: What Happens After Treatment? - If you have ABPA (Allergic Bronchopulmonary Aspergillosis), you’ve likely been told your IgE levels are high. Many patients ask: “Once […]
- 🏥 Surgery in Patients with ABPA or CPA: Can It Worsen Symptoms, and Should It Proceed? - Patients with Aspergillus-related lung diseases, such as Allergic Bronchopulmonary Aspergillosis (ABPA) and Chronic Pulmonary Aspergillosis (CPA), sometimes report worsened symptoms […]
Chronic pulmonary aspergillosis
- 📘 What is CPA? (Chronic Pulmonary Aspergillosis) - Patient handout for A&E staff who are not aware of aspergillosis. What is CPA? CPA is a chronic fungal infection […]
- 🏥 Surgery in Patients with ABPA or CPA: Can It Worsen Symptoms, and Should It Proceed? - Patients with Aspergillus-related lung diseases, such as Allergic Bronchopulmonary Aspergillosis (ABPA) and Chronic Pulmonary Aspergillosis (CPA), sometimes report worsened symptoms […]
- Chronic Pulmonary Aspergillosis (CPA) for Expert Patients and Non-Specialist Clinicians - Expert Information for Patients, GPs, and Specialist Nurses 🔎 What Is CPA? Chronic Pulmonary Aspergillosis (CPA) is a long-term fungal […]
Referral and specialist advice
Finding an Aspergillosis Expert – general guidance worldwide
- Can overseas patients access specialist centres like NAC? A clear guide for patients and families - Last reviewed: April 2026 Key points Specialist centres such as the National Aspergillosis Centre (NAC) cannot provide individual medical advice […]
- Patient referrals in the NHS – how it works - Here’s why GPs in the NHS usually refer patients first to a local specialist (e.g. a local respiratory team) rather […]
Patient information to share
You may also find these patient-facing resources useful during consultations:
Latest GP updates
- ERS learning resources on pulmonary aspergillosis (10/23/2026)
- Expertise shared across borders: an ABPA case discussion (10/23/2026)
- When symptoms remain difficult: keeping the conversation open (9/24/2026)
- Itraconazole for aspergillosis: benefits, monitoring and side effects (9/15/2026)
- ⭐ Allergic Bronchopulmonary Aspergillosis (ABPA): Why Diagnosis Is Missed and Who Needs to Be More Aware (8/27/2026)
- Isavuconazole in Aspergillosis (8/24/2026)
- Aspergillus Sinusitis for Expert Patients and non-Specialist Clinicians (8/17/2026)
- Weekly Aspergillosis Research Update: New Diagnostics, CAPA Evidence, and Why Azole Tolerance Matters (6/23/2026)
- About the National Aspergillosis Centre (NAC) (6/17/2026)
- Why the UK’s Infection Specialist Workforce Matters to People Living with Aspergillosis (6/17/2026)

